subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:3080587

object_name: breast carcinoma

tested_intervention: yes


subject: PUBCHEM.COMPOUND:3080587

object_name: breast cancer


subject: GTOPDB:4985

object_name: myeloproliferative neoplasm

tested_intervention: unsure


subject: GTOPDB:4985

object_name: bone marrow neoplasm


subject: GTOPDB:4985

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: GTOPDB:4985

object_name: Adult Myelodysplastic Syndrome


subject: GTOPDB:4985

object_name: childhood myelodysplastic syndrome


subject: GTOPDB:4985

object_name: Myelodysplastic Syndrome, CTCAE


subject: GTOPDB:4985

object_name: lymphoma, non-Hodgkin, familial


subject: GTOPDB:4985

object_name: Adult Non-Hodgkin Lymphoma


subject: GTOPDB:4985

object_name: Childhood Non-Hodgkin Lymphoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: CHEBI:180905

subject_name: Nicardipine

object_name: intracerebral hemorrhage


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905

object_name: subarachnoid hemorrhage


subject: CHEBI:6402

subject_name: Leflunomide

object_name: MEN1 Gene Mutation


subject: UNII:FBS88VEF1N

object_name: Alzheimer disease type 1


subject: UNII:FBS88VEF1N

object_name: Alzheimer disease


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: urethra neoplasm


subject: UNII:DLE8519RWM

object_name: benign urinary system neoplasm


subject: UNII:DLE8519RWM

object_name: urinary system neoplasm


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C3713874

object_name: Ewing sarcoma


subject: UMLS:C3713874

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C3713874

object_name: rhabdomyosarcoma


subject: UMLS:C3713874

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C3713874

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C3713874

object_name: Childhood Neuroblastoma


subject: UMLS:C3713874

object_name: neuroblastoma


subject: UMLS:C3713874

object_name: pediatric osteosarcoma


subject: UMLS:C3713874

object_name: Osteosarcoma


subject: CHEMBL.COMPOUND:CHEMBL2109310

object_name: peritoneum cancer


subject: CHEBI:167656

subject_name: Brivanib alaninate

object_name: endometrium adenocarcinoma


subject: CHEBI:167656

object_name: endometrial squamous cell carcinoma


subject: CHEBI:167656

object_name: squamous cell carcinoma of the corpus uteri


subject: CHEBI:167656

object_name: endometrial mucinous adenocarcinoma


subject: CHEBI:167656

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:167656

object_name: endometrial mixed adenocarcinoma


subject: CHEBI:167656

object_name: endometrial transitional cell carcinoma


subject: CHEBI:167656

object_name: transitional cell carcinoma of the corpus uteri


subject: CHEBI:167656

object_name: endometrial serous adenocarcinoma


subject: CHEBI:167656

object_name: endometrial undifferentiated carcinoma


subject: CHEBI:167656

object_name: undifferentiated carcinoma of the corpus uteri


subject: PUBCHEM.COMPOUND:2269

object_name: Wound Infection


subject: PUBCHEM.COMPOUND:2269

object_name: Wound Infection, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: Surgical Wound Infection


subject: PUBCHEM.COMPOUND:2269

object_name: endometritis


subject: PUBCHEM.COMPOUND:2269

object_name: abscess


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:93775

subject_name: Amethopterin

object_name: colorectal cancer


subject: CHEBI:93775

object_name: colorectal carcinoma


subject: CHEBI:93775

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:49603

subject_name: Lapatinib

object_name: pancreatic neoplasm


subject: CHEBI:49603

object_name: exocrine pancreatic carcinoma


subject: CHEBI:49603

object_name: malignant pancreatic neoplasm


subject: CHEBI:2704

subject_name: Anastrozole

object_name: type 2 diabetes mellitus


subject: CHEBI:2704

object_name: Insulin resistance


subject: CHEBI:521033

subject_name: Dutasteride


subject: CHEBI:521033


subject: CHEBI:521033

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:521033

object_name: obesity


subject: CHEBI:521033

object_name: Obesity, CTCAE


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist


subject: UMLS:C1268855


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: UMLS:C3537040


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:215747

subject_name: Tapinarof

object_name: palmoplantar keratosis


subject: CHEBI:215747

object_name: Palmoplantar keratoderma


subject: CHEBI:31547

subject_name: Eplerenone


subject: CHEBI:31547

object_name: glucose intolerance


subject: CHEBI:31547

object_name: Glucose Intolerance, CTCAE


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: atrial fibrillation


subject: MESH:D000077203

object_name: Atrial Fibrillation by ECG Finding


subject: MESH:D000077203

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3542461


subject: UMLS:C3542461


subject: CHEBI:59585

object_name: osteoarthritis susceptibility 6


subject: CHEBI:59585

object_name: osteoarthritis, knee


subject: UMLS:C0162357

subject_name: Clodronate


subject: UMLS:C0162357


subject: CHEBI:110423

subject_name: Clodronic acid


subject: CHEBI:110423


subject: UNII:7N8K34P2XH

subject_name: Detomidine

object_name: cesarean section; complications


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Childhood Breast Carcinoma


subject: CHEBI:38290

object_name: breast carcinoma


subject: CHEBI:38290

object_name: breast cancer


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Sepsis


subject: CHEBI:107736

object_name: Sepsis, CTCAE


subject: HMDB:HMDB0001349

subject_name: Selenium


subject: HMDB:HMDB0001349


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C5418104

subject_name: Fluorescent Imaging Agent cRGD-ZW800-1

object_name: cholangiocarcinoma


subject: UMLS:C5418104

object_name: pancreatic adenocarcinoma


subject: MESH:C000594495

subject_name: an-gong-niu-huang wan

object_name: Stroke (CVA) or TIA


subject: UMLS:C5417812

subject_name: Finotonlimab

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:126843196

subject_name: Recombinant insulin Human

object_name: type 1 diabetes mellitus


subject: UMLS:C1446598

subject_name: Recombinant human regular insulin


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Graves disease


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:3561

subject_name: Cetirizine

object_name: dermatitis


subject: CHEBI:3561

object_name: Dermatitis


subject: CHEBI:94559

subject_name: Levocetirizine


subject: CHEBI:94559


subject: UMLS:C3541972

subject_name: Carbohydrate nutrients

object_name: Traumatic dislocation of joint of cervical vertebra


subject: UMLS:C3541972

object_name: thyroid tumor


subject: CHEBI:16646

subject_name: carbohydrate


subject: CHEBI:16646


subject: CHEBI:3175

subject_name: Brimonidine

object_name: Pseudophakia


subject: CHEBI:39462

subject_name: pilocarpine


subject: CHEBI:39462

object_name: presbyopia


subject: CHEBI:8207

subject_name: Pilocarpine


subject: CHEBI:6801

subject_name: Metformin

object_name: Endoplasmic Reticulum Stress


subject: CHEBI:6801

object_name: viral disease


subject: CHEBI:6801

object_name: yellow fever


subject: CHEBI:125628

subject_name: Alisertib

object_name: pancreatic neoplasm


subject: CHEBI:125628

object_name: esophageal adenocarcinoma


subject: CHEBI:125628

object_name: lung adenocarcinoma


subject: CHEBI:125628

object_name: cervical adenocarcinoma


subject: CHEBI:125628

object_name: adenocarcinoma


subject: CHEBI:125628

object_name: bile duct adenocarcinoma


subject: CHEBI:125628

object_name: gastric adenocarcinoma


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: triple-negative breast carcinoma


subject: UNII:68AYS9A614

object_name: ovarian serous surface papillary adenocarcinoma


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:52717

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:63632

subject_name: Topotecan

object_name: Unresectable Solid Neoplasm


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: laryngeal disorder


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Inflammation


subject: PUBCHEM.COMPOUND:46783403

object_name: Parkinson disease


subject: UMLS:C5787192

subject_name: LAM 561

object_name: glioblastoma


subject: CHEBI:74224

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:74224

object_name: metabolic syndrome X


subject: CHEBI:74224

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:74224

object_name: obesity


subject: CHEBI:74224

object_name: Obesity, CTCAE


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:28088

subject_name: Genistein


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: UMLS:C5237268

subject_name: Gallium Ga 68 FAPi-46

object_name: ductal breast carcinoma in situ


subject: UMLS:C5926468

subject_name: FAPi-46 GA-68


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: insomnia


subject: CHEBI:9943

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:9943

object_name: Insomnia, CTCAE 5.0


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: nicotine dependence


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: interstitial lung disease 1


subject: CHEBI:15927

object_name: interstitial lung disease 2


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: UMLS:C2348288


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: CHEBI:32599

object_name: Premature birth


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Postmenopausal osteopenia


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: ST Elevation Myocardial Infarction


subject: UMLS:C0042210

subject_name: Vaccines

object_name: pancreatic adenocarcinoma


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C4764331


subject: UMLS:C5418018

subject_name: SIRPa-Fc-CD40L Fusion Protein SL-172154

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5418018

object_name: acute myeloid leukemia


subject: UMLS:C5418018

object_name: Myelodysplasia


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: beta thalassemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: sickle cell disease


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:13450

subject_name: briquilimab


subject: GTOPDB:13450


subject: UNII:QWX84D0DRC

subject_name: BRIQUILIMAB


subject: UNII:QWX84D0DRC


subject: UMLS:C5418059

subject_name: AMG 191


subject: UMLS:C5418059


subject: CHEBI:7421

subject_name: NAC

object_name: Dialysis Catheter Infection


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:142708


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: CHEBI:149836

subject_name: Tigecycline


subject: UNII:NA1U919MRO

subject_name: Difelikefalin

object_name: Uremic pruritus


subject: PUBCHEM.COMPOUND:76211403

subject_name: Eravacycline

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:76211403

object_name: leukopenia


subject: PUBCHEM.COMPOUND:76211403

object_name: neutropenia


subject: UNII:07896928ZC


subject: UNII:07896928ZC


subject: UNII:07896928ZC


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: Nasal Polyp


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: colon carcinoma


subject: CHEBI:68646

object_name: colon cancer


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: benign prostatic hyperplasia


subject: UMLS:C0971731


subject: PUBCHEM.COMPOUND:152165

object_name: Irreversible pulpitis


subject: CHEBI:174348

object_name: Post-Operative Pain


subject: CHEBI:174348


subject: CHEBI:6717

subject_name: Mefenamic acid


subject: CHEBI:6717


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632

object_name: colorectal cancer


subject: CHEBI:63632


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: unspecified adult solid tumor, protocol specific


subject: PR:000005931


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Locally Advanced Rectal Adenocarcinoma


subject: CHEBI:231679

object_name: Stage II Rectal Cancer AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:32010

subject_name: Piracetam

object_name: Memory Disorders


subject: UMLS:C0376196

subject_name: Opiates

object_name: chronic pain syndrome


subject: MESH:D053610

subject_name: Opiate Alkaloids


subject: CHEBI:135193

subject_name: Fospropofol

object_name: Complication of injection


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Acute viral bronchiolitis


subject: CHEBI:135810

subject_name: Atrasentan

object_name: diabetic kidney disease


subject: UMLS:C1176021

object_name: bladder tumor


subject: UMLS:C1176021

object_name: urinary bladder carcinoma


subject: UMLS:C1176021

object_name: urinary bladder cancer


subject: UMLS:C1176021

object_name: childhood bladder carcinoma


subject: CHEBI:18248

subject_name: Iron

object_name: Zinc deficiency


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Iron deficiency


subject: UMLS:C2348288

object_name: iron deficiency anemia


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: CHEBI:16302


subject: CHEBI:16302


subject: CHEBI:16302


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: respiratory failure


subject: UMLS:C3714501

object_name: Respiratory Failure, CTCAE


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: UMLS:C0885467

subject_name: Juglans regia preparation

object_name: Upper Respiratory Infections


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: skin melanoma


subject: UMLS:C5544267

object_name: Duchenne muscular dystrophy


subject: CHEBI:16134

subject_name: Ammonia

object_name: coronary artery disorder


subject: CHEBI:16134

object_name: coronary atherosclerosis


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: type 2 diabetes mellitus


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: Helicobacter pylori infection


subject: CHEBI:41423

subject_name: Celecoxib

object_name: No Evidence of Disease


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: bipolar disorder


subject: CHEBI:8356

subject_name: Pramipexole


subject: UMLS:C0767948

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0767948

object_name: acute myeloid leukemia


subject: UMLS:C1828021

subject_name: Copper (64-Cu) diacetyl-bis N-(4)-methylthiosemicarbazone

object_name: cervical cancer


subject: UMLS:C1828021

object_name: cervical carcinoma


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: UNII:1351PE5UGS

subject_name: Elotuzumab

object_name: plasma cell leukemia


subject: UNII:3CM03MUJ69

subject_name: Ingavirin

object_name: viral disease


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: mortality


subject: CHEBI:135954

subject_name: Bilastine

object_name: Allergic rhinoconjunctivitis


subject: CHEBI:6801

subject_name: Metformin

object_name: Pediatric Obesity


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3827082


subject: UMLS:C5854639

subject_name: IL-12-Fc Fusion Protein XmAb662

object_name: Solid Neoplasm


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Childhood Brain Neoplasm


subject: CHEBI:168243

object_name: medulloblastoma


subject: CHEBI:168243

object_name: childhood medulloblastoma


subject: CHEBI:168243

object_name: adult medulloblastoma


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: UNII:ZAU91150SB

subject_name: Tefinostat

object_name: hematologic disorder


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: sickle cell disease


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Coronavinae infectious disease


subject: UMLS:C0042210

object_name: Critical Illness


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: MESH:C000624565

subject_name: ProRoot MTA

object_name: Periapical abscess no sinus


subject: MESH:C000624565

object_name: suppurative periapical periodontitis


subject: UMLS:C0056499

subject_name: CRM197 (non-toxic variant of diphtheria toxin)

object_name: meningococcal meningitis


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: nasopharyngeal carcinoma


subject: UNII:KXG2PJ551I

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:KXG2PJ551I

object_name: malignant tumor of nasopharynx


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IV adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:76192587

subject_name: Ombitasvir

object_name: Adverse reaction to antiviral drugs


subject: CHEBI:85188

subject_name: paritaprevir


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: HIV infection


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:68595

subject_name: Telaprevir

object_name: Depressed mood


subject: CHEBI:68595

object_name: Cancer patients and suicide and depression


subject: CHEBI:68595

object_name: Depressed - symptom


subject: CHEBI:68595

object_name: Depression, CTCAE


subject: CHEBI:3219

subject_name: Bupropion

object_name: type 2 diabetes mellitus


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: anal margin carcinoma


subject: UNII:6A901E312A

object_name: anal squamous cell carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: UMLS:C0281671

subject_name: ImmTher

object_name: Ewing sarcoma


subject: CHEBI:10782

subject_name: Perilla alcohol

object_name: Childhood Breast Carcinoma


subject: CHEBI:10782

object_name: breast carcinoma


subject: CHEBI:10782

object_name: breast cancer


subject: CHEBI:145806

subject_name: (R)-(+)-perillyl alcohol


subject: CHEBI:145806


subject: CHEBI:145806


subject: CHEBI:15420

subject_name: perillyl alcohol


subject: CHEBI:15420


subject: CHEBI:15420


subject: UMLS:C5854579

subject_name: Allogeneic EBV-transformed B-lymphoblastoid Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine KSD-101

object_name: nasopharyngeal carcinoma


subject: UMLS:C5854579

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C0699618

subject_name: Saizen

object_name: Congenital IGHD


subject: UMLS:C0699618

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C0699618

object_name: Growth delay


subject: UMLS:C0699618

object_name: Failure to Thrive


subject: UMLS:C0355946

subject_name: Antipseudomonal penicillin

object_name: neurotoxicity


subject: UMLS:C0355946

object_name: Sepsis


subject: UMLS:C0355946

object_name: Sepsis, CTCAE


subject: UMLS:C0355946

object_name: acute kidney failure


subject: CHEBI:234329

object_name: diffuse large B-cell lymphoma


subject: CHEBI:234329

object_name: Burkitt lymphoma


subject: CHEBI:234329

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:234329

object_name: Adult Burkitt Lymphoma


subject: CHEBI:234329

object_name: Adult Solid Neoplasm


subject: UMLS:C3642150


subject: UMLS:C3642150


subject: UMLS:C3642150


subject: UMLS:C3642150


subject: UMLS:C3642150


subject: MESH:C000627770

subject_name: folfirinox

object_name: Effects of chemotherapy


subject: PUBCHEM.COMPOUND:86278354

subject_name: Emapticap pegol

object_name: Inflammation


subject: PUBCHEM.COMPOUND:86278354

object_name: Chronic Disease


subject: UNII:CTL75X0V60


subject: UNII:CTL75X0V60


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:49040

subject_name: Ezetimibe


subject: CHEBI:94770

subject_name: Pirarubicin

object_name: renal pelvis/ureter urothelial carcinoma


subject: UMLS:C3181684

object_name: neoplasm


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Constipation


subject: CHEBI:60802

object_name: Constipation, CTCAE


subject: CHEBI:60802

object_name: dizziness


subject: CHEBI:60802

object_name: Dizziness, CTCAE 5.0


subject: CHEBI:60802

object_name: Dizziness, CTCAE 3.0


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: Nocturnal polyuria


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: UMLS:C1328123

subject_name: Allogeneic Tumor Cell Vaccine

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:31355

subject_name: Carboplatin

object_name: desmoplastic/nodular medulloblastoma


subject: CHEBI:31355

object_name: medulloblastoma with extensive nodularity


subject: CHEBI:31355

object_name: nevoid basal cell carcinoma syndrome


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: UNII:T5IRO3534A

subject_name: Oncovin

object_name: medulloblastoma


subject: UNII:T5IRO3534A

object_name: childhood medulloblastoma


subject: UNII:T5IRO3534A

object_name: adult medulloblastoma


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:6843

subject_name: Methoxyflurane

object_name: acute pain due to trauma


subject: CHEBI:93775

object_name: Aortic stiffness


subject: CHEBI:93775

object_name: coronary microvascular disorder


subject: CHEBI:93775

object_name: Heart Disease Risk Factors


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:8871

subject_name: Risperidone

object_name: Aggressive behavior


subject: CHEBI:8871

object_name: Aggression


subject: CHEBI:63925

subject_name: PhXa 85

object_name: angle-closure glaucoma


subject: UNII:6ST3ZF52WB

subject_name: Carboxyamidotriazole

object_name: adult glioblastoma


subject: UNII:6ST3ZF52WB

object_name: Adult Giant Cell Glioblastoma


subject: UNII:6ST3ZF52WB

object_name: Adult Gliosarcoma


subject: PR:000022283

subject_name: excinuclease cho

object_name: Prediabetes


subject: UniProtKB:P76213

subject_name: CHO_ECOLI Excinuclease cho (sprot)


subject: CHEBI:16646

subject_name: carbohydrate


subject: MESH:D000073893

subject_name: Sugars


subject: UMLS:C3665462

subject_name: raw sugar


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY


subject: CHEBI:36704

subject_name: Imiquimod

object_name: plantar wart


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: atopic eczema


subject: CHEBI:6970

subject_name: Mometasone


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: Endometrial neoplasm malignant stage I


subject: CHEBI:17026

subject_name: Progesterone


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Reperfusion Injury


subject: CHEBI:42797

subject_name: Gabapentin

object_name: head and neck squamous cell carcinoma


subject: CHEBI:42797

object_name: stomatitis


subject: CHEBI:167309

subject_name: Methadone


subject: CHEBI:167309


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:7852


subject: CHEBI:71013

subject_name: Perampanel

object_name: Kinetic tremor


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: Dyspnea


subject: UMLS:C2697920

object_name: lung cancer


subject: UMLS:C2697920

object_name: lung neoplasm


subject: UMLS:C2697920

object_name: lung carcinoma


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: Acute Ischemic Stroke


subject: CHEBI:94789

object_name: Ischemic stroke


subject: CHEBI:26536

subject_name: retinoic acid

object_name: Childhood Neuroblastoma


subject: CHEBI:26536

object_name: neuroblastoma


subject: CHEBI:26536

object_name: neuroendocrine neoplasm


subject: CHEBI:26536

object_name: APUdoma


subject: CHEBI:28870


subject: CHEBI:28870


subject: CHEBI:28870


subject: CHEBI:28870


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:15367


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:6067

subject_name: Isotretinoin


subject: CHEBI:6067


subject: UNII:X6SH5T8H76

object_name: Childhood Solid Neoplasm


subject: UNII:X6SH5T8H76

object_name: Adult Solid Neoplasm


subject: UNII:X6SH5T8H76

object_name: Solid Neoplasm


subject: UNII:X6SH5T8H76

object_name: pancreatic adenocarcinoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: nephroblastoma


subject: CHEBI:71219

object_name: Wilms tumor


subject: CHEBI:71219

object_name: childhood kidney Wilms tumor


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219

object_name: pediatric osteosarcoma


subject: CHEBI:71219

object_name: Osteosarcoma


subject: UMLS:C1327963

object_name: brain neoplasm


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963


subject: UMLS:C1327963

object_name: malignant soft tissue neoplasm


subject: UMLS:C1327963

object_name: sarcoma


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Frailty


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C0751598

subject_name: Alferon

object_name: pancreatic neoplasm


subject: UMLS:C0751598

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0751598

object_name: malignant pancreatic neoplasm


subject: UMLS:C5206469

subject_name: Platinum Doublet

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5206469

object_name: liver carcinoma


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UMLS:C4053601


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB


subject: UNII:OX5LRQ5H6K


subject: UMLS:C4329332

subject_name: Fianlimab


subject: UMLS:C4329332


subject: UNII:4ON7FF680U

subject_name: TUCOTUZUMAB CELMOLEUKIN

object_name: lung cancer


subject: UNII:4ON7FF680U

object_name: lung neoplasm


subject: UNII:4ON7FF680U

object_name: lung carcinoma


subject: UNII:4ON7FF680U

object_name: bladder tumor


subject: UNII:4ON7FF680U

object_name: urinary bladder carcinoma


subject: UNII:4ON7FF680U

object_name: urinary bladder cancer


subject: UNII:4ON7FF680U

object_name: childhood bladder carcinoma


subject: UNII:4ON7FF680U

object_name: renal carcinoma


subject: UNII:4ON7FF680U

object_name: kidney neoplasm


subject: UNII:4ON7FF680U

object_name: kidney cancer


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: UMLS:C1530077


subject: CHEBI:33325

subject_name: radium atom

object_name: Childhood Breast Carcinoma


subject: CHEBI:33325

object_name: breast carcinoma


subject: CHEBI:33325

object_name: breast cancer


subject: UMLS:C3827153


subject: UMLS:C3827153


subject: UMLS:C3827153


subject: PUBCHEM.COMPOUND:122670110

object_name: asthma


subject: GTOPDB:13448

object_name: Allergy


subject: GTOPDB:13448

object_name: chronic idiopathic urticaria


subject: GTOPDB:13448

object_name: chronic inducible urticaria


subject: GTOPDB:13448

object_name: cold urticaria


subject: UNII:FB7ZTJ8M8A

object_name: arteriosclerosis disorder


subject: UNII:FB7ZTJ8M8A

object_name: atherosclerosis


subject: UMLS:C4045864


subject: UMLS:C4045864


subject: CHEBI:5775

subject_name: Hydralazine

object_name: severe pre-eclampsia


subject: CHEBI:167638

subject_name: Labetalol


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: spinal cord injury


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Conn's syndrome


subject: CHEBI:166975

subject_name: soybean oil

object_name: no feeling or sensation of skin


subject: CHEBI:166975

object_name: Sensory Loss


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: DRUGBANK:DB09422


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Diabetic peripheral neuropathic pain


subject: UMLS:C0939261

subject_name: B-Complex


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:68579

object_name: carotid stenosis


subject: CHEBI:229236

subject_name: Fezolinetant

object_name: Hepatic impairment


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: gastric cancer


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: DRUGBANK:DB05572


subject: CHEBI:109549

subject_name: Ramelteon

object_name: sleep disorder, initiating and maintaining sleep


subject: UNII:851NLB57HQ

subject_name: E-DOXEPIN


subject: CHEBI:4710

subject_name: Doxepin


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: influenza


subject: UNII:U6N7333GDW

subject_name: Nesuparib

object_name: endometrial cancer


subject: UNII:U6N7333GDW

object_name: uterine corpus cancer


subject: UNII:U6N7333GDW

object_name: endometrial carcinoma


subject: UNII:U6N7333GDW

object_name: Recurrent Endometrial Cancer


subject: UNII:U6N7333GDW

object_name: endometrium neoplasm


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: Severe major depression


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Richter syndrome


subject: CHEBI:28680

subject_name: Cytarabine


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: Chronic post-traumatic headache


subject: UMLS:C3661049

object_name: chorea


subject: UMLS:C3661049

object_name: Huntington disease


subject: CHEBI:31550

subject_name: Patupilone

object_name: non-small cell lung carcinoma


subject: CHEBI:25017

subject_name: leucine

object_name: pyridoxine deficiency anemia


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: thyroid tumor


subject: PUBCHEM.COMPOUND:3844471

object_name: thyroid gland carcinoma


subject: PUBCHEM.COMPOUND:3844471

object_name: thyroid cancer


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: GTOPDB:6788

subject_name: drotrecogin alfa

object_name: Severe Sepsis


subject: UMLS:C1170000


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C4329329

object_name: ERBB2 mutation-related tumors


subject: UMLS:C4329329


subject: UMLS:C5700426

subject_name: furmonertinib


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:31355

subject_name: Carboplatin


subject: UMLS:C0071315

subject_name: Pneumovax

object_name: pneumonia


subject: UMLS:C0071315

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C0876134

subject_name: Prevnar


subject: UMLS:C0876134


subject: UMLS:C4507843

object_name: diabetic kidney disease


subject: UMLS:C4507843

object_name: type 2 diabetes mellitus


subject: CHEBI:2639

subject_name: Amiloride

object_name: coronary atherosclerosis


subject: UNII:82W826FL6S

subject_name: MILCICLIB MALEATE

object_name: type C thymoma


subject: UNII:688000M8S8

subject_name: MILCICLIB


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Physical trauma


subject: UMLS:C0445115

object_name: Injury


subject: UMLS:C0445115

object_name: Trauma


subject: PUBCHEM.COMPOUND:6335487


subject: PUBCHEM.COMPOUND:6335487


subject: PUBCHEM.COMPOUND:6335487


subject: MESH:D000077325

subject_name: Ringer's Lactate


subject: MESH:D000077325


subject: MESH:D000077325


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: long COVID-19


subject: UMLS:C0085297

object_name: Chronic post-COVID-19 syndrome


subject: UNII:C8ADC441ME

subject_name: Ivabradine


subject: UNII:C8ADC441ME


subject: CHEBI:16563

subject_name: Tetrahydropalmatine

object_name: cocaine use


subject: CHEBI:16563

object_name: Cocaine user


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: Drooling


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:6121

subject_name: Ketamine

object_name: Status epilepticus


subject: CHEBI:8069

subject_name: Phenobarbital


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide


subject: CHEBI:114785

subject_name: Erlotinib

object_name: tumor suppressor gene on chromosome 11


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:35111

subject_name: calcium monohydroxide

object_name: periapical periodontitis


subject: CHEBI:35150

subject_name: calcium hydroxide


subject: CHEBI:31341

subject_name: calcium dihydroxide


subject: UNII:UVJ7NL8S2P

subject_name: Imlifidase

object_name: end stage renal failure


subject: UNII:UVJ7NL8S2P

object_name: Chronic uremia


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: stroke disorder


subject: UNII:I031V2H011

object_name: cerebrovascular disorder


subject: UNII:I031V2H011

object_name: Stroke (heart beat)


subject: UNII:I031V2H011

object_name: Stroke, CTCAE


subject: UNII:I031V2H011

object_name: Acquired foot drop (finding)


subject: UNII:I031V2H011

object_name: Foot Drop


subject: UNII:I031V2H011

object_name: hemiplegia


subject: UNII:I031V2H011

object_name: Steppage gait


subject: PR:000023317


subject: PR:000023317


subject: PR:000023317


subject: PR:000023317


subject: PR:000023317


subject: PR:000023317


subject: PR:000023317


subject: PR:000023317


subject: CHEBI:23994

subject_name: ethyl methanesulfonate


subject: CHEBI:23994


subject: CHEBI:23994


subject: CHEBI:23994


subject: CHEBI:23994


subject: CHEBI:23994


subject: CHEBI:23994


subject: CHEBI:23994


subject: CHEBI:8746

subject_name: Levosalbutamol

object_name: primary pulmonary hypertension


subject: CHEBI:8746

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Penile curvature


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: lupus cutaneous


subject: CHEBI:58097

object_name: Urinary Urgency


subject: CHEBI:58097

object_name: Neurogenic bladder


subject: CHEBI:58097

object_name: interstitial cystitis


subject: CHEBI:58097

object_name: Painful Bladder Syndrome


subject: CHEBI:58097

object_name: urgency urinary incontinence


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEMBL.COMPOUND:CHEMBL2108906

subject_name: BELLADONNA


subject: CHEMBL.COMPOUND:CHEMBL2108906


subject: CHEMBL.COMPOUND:CHEMBL2108906


subject: CHEMBL.COMPOUND:CHEMBL2108906


subject: CHEMBL.COMPOUND:CHEMBL2108906


subject: CHEBI:76842

object_name: ulcerative colitis


subject: CHEBI:76842

object_name: inflammatory bowel disease 1


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:78236

subject_name: N-acetyl-L-cysteinate

object_name: complications of organ transplant stem cells


subject: UNII:2SPH1IMO2V

subject_name: N-Acetyl-D-cysteine


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: DRUGBANK:DB05069

object_name: age-related macular degeneration


subject: CHEBI:6706

subject_name: Mecamylamine


subject: UMLS:C3713962

object_name: Parkinson disease


subject: UMLS:C3713962

object_name: Huntington disease


subject: CHEBI:4466

object_name: Inguinal hernia


subject: UNII:7N8K34P2XH


subject: UMLS:C4329329

object_name: HER2 protein overexpression


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: CHEBI:16899

subject_name: Mannitol

object_name: Cis-platinum nephropathy


subject: CHEBI:16899

object_name: Mannitol adverse reaction


subject: CHEBI:9150

subject_name: Simvastatin

object_name: pachyonychia congenita


subject: UMLS:C5442039

subject_name: FGF Receptor Antagonist HGS1036

object_name: cancer


subject: UMLS:C5442039

object_name: neoplasm


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: pulmonary hypertension, primary, 1


subject: UNII:4F4X42SYQ6

object_name: pulmonary hypertension


subject: UNII:4F4X42SYQ6

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:4F4X42SYQ6

object_name: pulmonary arterial hypertension


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C3850511

object_name: septic shock


subject: UMLS:C3850511

object_name: Severe Sepsis


subject: RXCUI:1999664

subject_name: bictegravir / emtricitabine / tenofovir alafenamide Oral Product

object_name: sexually transmitted disease


subject: UMLS:C5783443

subject_name: KRAS G12C Inhibitor IBI351

object_name: colorectal cancer


subject: UMLS:C5783443

object_name: colorectal carcinoma


subject: UMLS:C5783443

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:19092

object_name: primary pulmonary hypertension


subject: CHEBI:19092


subject: UNII:YL48YW74QQ


subject: UNII:YL48YW74QQ


subject: CHEBI:80131


subject: CHEBI:80131


subject: CHEBI:147395


subject: CHEBI:147395


subject: UNII:GF5K6G6AH3


subject: UNII:GF5K6G6AH3


subject: UMLS:C1531139

subject_name: apelin-13 peptide


subject: UMLS:C1531139


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:54675783

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:54675783

object_name: malignant pancreatic neoplasm


subject: CHEBI:132922

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:132922

object_name: obesity


subject: CHEBI:132922

object_name: Obesity, CTCAE


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:9150

object_name: intracerebral hemorrhage


subject: UMLS:C3839895

subject_name: Vemurafenib 240 mg oral capsule

object_name: melanoma


subject: CHEBI:194095

subject_name: mitomycin C(1-)


subject: CHEBI:194095


subject: CHEBI:194095


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:71015

subject_name: perampanel hydrate

object_name: Menstrual epilepsy


subject: CHEBI:71013

subject_name: Perampanel


subject: UMLS:C0282090

subject_name: Laxatives

object_name: Chronic idiopathic constipation


subject: UMLS:C2348466

object_name: plasma cell myeloma


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: laryngeal squamous cell carcinoma


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:44915

subject_name: Propofol

object_name: Kinetic tremor


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection

object_name: Childhood Solid Neoplasm


subject: UMLS:C5400115

object_name: Adult Solid Neoplasm


subject: UMLS:C5400115

object_name: Solid Neoplasm


subject: GTOPDB:13304

subject_name: datopotamab deruxtecan

object_name: Carcinoma breast stage IV


subject: GTOPDB:13304

object_name: HER2 low breast cancer


subject: UNII:GD2OWY1DTK

subject_name: DATOPOTAMAB DERUXTECAN


subject: UNII:GD2OWY1DTK


subject: UMLS:C4726586

subject_name: ADC DS-1062a


subject: UMLS:C4726586


subject: UNII:SE2KH7T06F


subject: UMLS:C4287766


subject: CHEBI:31355

subject_name: Carboplatin

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:31355

object_name: fibrolamellar hepatocellular carcinoma


subject: CHEBI:31355

object_name: Hepatocellular Malignant Neoplasm, Not Otherwise Specified


subject: CHEBI:31355

object_name: Childhood Malignant Liver Neoplasm


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:64816

object_name: hepatoblastoma


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: UNII:T5IRO3534A

subject_name: Oncovin

object_name: liver carcinoma


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:16856

subject_name: Glutathione

object_name: schizophrenia


subject: UMLS:C5834390

subject_name: Liposomal glutathione


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Headache


subject: CHEBI:25805

object_name: Headache, CTCAE


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: PUBCHEM.COMPOUND:152165

object_name: Depression suicidal


subject: CHEBI:47381

subject_name: Diclofenac


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Locally Advanced Sarcoma


subject: UNII:6QVL057INT

object_name: Metastasis


subject: UNII:6QVL057INT

object_name: Metastatic Lesion


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C5435429

object_name: Functional constipation


subject: CHEBI:50692

subject_name: Mifepristone

object_name: abortion; medical, fetus


subject: CHEBI:63610

subject_name: Misoprostol


subject: UNII:Q6C9WHR03O

subject_name: tisagenlecleucel

object_name: leukemia


subject: UNII:Q6C9WHR03O

object_name: childhood leukemia


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: cardiotoxicity


subject: CHEBI:6456

subject_name: Lidocaine

object_name: shoulder pain chronic


subject: CHEBI:6456

object_name: chronic shoulder pain


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:132922

object_name: Forearm Injuries


subject: CHEBI:132922

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:132922

object_name: Acute Pain


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:7852


subject: CHEBI:229212

subject_name: Pirtobrutinib

object_name: liver failure


subject: UMLS:C1095795

subject_name: EGb 761

object_name: Neurologic Deficits


subject: UMLS:C1095795

object_name: Acute Stroke


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Resectable non-small cell lung cancer


subject: UMLS:C3827082


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:4672


subject: CHEBI:4672

object_name: Stage II Lung Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: UNII:4HA45S22ZZ

object_name: malignant glioma


subject: CHEBI:67271


subject: PUBCHEM.COMPOUND:127236

object_name: Relapse multiple myeloma


subject: PUBCHEM.COMPOUND:127236

object_name: Plasma cell myeloma recurrent


subject: PR:000001406

subject_name: tumor necrosis factor receptor superfamily member 17


subject: PR:000001406


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Primary hypothyroidism


subject: CHEBI:38290

object_name: hypothyroidism


subject: CHEBI:38290

object_name: Hypothyroidism, CTCAE


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: hepatoid adenocarcinoma of stomach


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:32188

subject_name: Tegafur


subject: CHEBI:31652

subject_name: Gimeracil


subject: CHEBI:78351

subject_name: amantadine sulfate

object_name: chronic hepatitis C virus infection


subject: CHEBI:2618

subject_name: Amantadine


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Refractory drug response


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:32314

subject_name: Geodon

object_name: schizoaffective disorder


subject: CHEBI:32314

object_name: schizophrenia 18


subject: CHEBI:32314

object_name: schizophrenia


subject: CHEBI:5002

subject_name: Fenoldopam

object_name: patent ductus arteriosus


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: Fatty Liver


subject: CHEBI:63717


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63625


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: UniProtKB:P36394


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PR:000015643


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:60481


subject: CHEBI:60481


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: PR:000008953


subject: PUBCHEM.COMPOUND:131801470

subject_name: Beinaglutide

object_name: Overweight or obesity


subject: PUBCHEM.COMPOUND:131801470

object_name: type 2 diabetes mellitus


subject: UNII:38I1O6L31D

subject_name: BEINAGLUTIDE


subject: UNII:38I1O6L31D


subject: UMLS:C5139820


subject: UMLS:C5139820


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: plasma cell myeloma


subject: CHEBI:62880

subject_name: Veliparib

object_name: basal-like breast carcinoma


subject: CHEBI:62880

object_name: Progesterone Receptor Negative


subject: CHEBI:62880

object_name: Estrogen Receptor Negative


subject: CHEBI:62880

object_name: prostate carcinoma


subject: CHEBI:62880

object_name: HER2/Neu Negative


subject: UNII:5QS67N4551

subject_name: Conestat alfa

object_name: Acute Ischemic Stroke


subject: UNII:5QS67N4551

object_name: Ischemic stroke


subject: UMLS:C3898587

subject_name: Liposomal Mitoxantrone Hydrochloride

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3898587

object_name: acute myeloid leukemia


subject: CHEBI:64816

object_name: acute biphenotypic leukemia


subject: CHEBI:64816

object_name: mixed phenotype acute leukemia


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: UNII:E8R04MBQ04


subject: UNII:E8R04MBQ04


subject: UNII:E8R04MBQ04

object_name: acute leukemia of ambiguous lineage


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: CHEBI:90942

subject_name: Ixazomib


subject: CHEBI:90942


subject: CHEBI:90942


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: subarachnoid hemorrhage


subject: UMLS:C1704264

subject_name: Interleukin 1 Receptor Antagonist Protein


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UMLS:C5234969

subject_name: Cam

object_name: musculoskeletal system disorder


subject: UMLS:C5234969

object_name: Traumatic Wound


subject: UMLS:C5234969

object_name: Injury


subject: UMLS:C5234969

object_name: Wounds and Injuries


subject: UMLS:C0678112

subject_name: CAM brand of Ephedrine Hydrochloride


subject: UMLS:C0678112


subject: UMLS:C0678112


subject: UMLS:C0678112


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:3732


subject: CHEBI:3732


subject: CHEBI:3732


subject: UniProtKB:P62158

subject_name: Calmodulin 1


subject: UniProtKB:P62158


subject: UniProtKB:P62158


subject: UniProtKB:P62158


subject: UniProtKB:P0DP23

subject_name: CALM1_HUMAN Calmodulin-1 (sprot)


subject: UniProtKB:P0DP23


subject: UniProtKB:P0DP23


subject: UniProtKB:P0DP23


subject: UMLS:C0007578

subject_name: Cell Adhesion Molecules


subject: UMLS:C0007578


subject: UMLS:C0007578


subject: UMLS:C0007578


subject: UniProtKB:P0DP29

subject_name: CALM1_RAT Calmodulin-1 (sprot)


subject: UniProtKB:P0DP29


subject: UniProtKB:P0DP29


subject: UniProtKB:P0DP29


subject: PR:000049739

subject_name: calmodulin (rat)


subject: PR:000049739


subject: PR:000049739


subject: PR:000049739


subject: UniProtKB:P62157

subject_name: CALM_BOVIN Calmodulin (sprot)


subject: UniProtKB:P62157


subject: UniProtKB:P62157


subject: UniProtKB:P62157


subject: PR:000004978

subject_name: calmodulin


subject: PR:000004978


subject: PR:000004978


subject: PR:000004978


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: myeloid leukemia


subject: UNII:4FR53SIF3A

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Frailty


subject: CHEBI:36005

object_name: osteoporosis


subject: CHEBI:36005

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:36005

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:36005

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: CHEBI:28364


subject: CHEBI:28364


subject: CHEBI:28364


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: postpoliomyelitis syndrome


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: inherited disease susceptibility


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Disorder of coccyx


subject: UNII:U8S0IC8DY7

object_name: HIV-1 infection


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:70839

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:141439

subject_name: Ile-Asp

object_name: influenza


subject: UniProtKB:P20067

subject_name: ID1_MOUSE DNA-binding protein inhibitor ID-1 (sprot)


subject: PR:000000039

subject_name: DNA-binding protein inhibitor ID-1


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Stage IA Lung Non-Small Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:1805

object_name: stage IIA non-small cell lung cancer


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:1805

object_name: stage IB non-small cell lung cancer


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:1805

object_name: stage IIB non-small cell lung cancer


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:132082

subject_name: Entinostat


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:3745

subject_name: clindamycin

object_name: Supracondylar fracture of humerus


subject: CHEBI:3745

object_name: Surgical Wound Infection


subject: CHEBI:63610

subject_name: Misoprostol

object_name: anemia


subject: CHEBI:63610

object_name: Anemia, CTCAE


subject: CHEBI:31485

subject_name: Difluprednate

object_name: panuveitis


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: aspergillosis; pulmonary, invasive (etiology)


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:7V6HE3DM5A

subject_name: Ocriplasmin

object_name: diabetic macular edema


subject: CHEBI:499361

subject_name: Aprepitant

object_name: glioma


subject: CHEBI:499361

object_name: malignant glioma


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Postoperative delirium


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: Adult Meningioma


subject: CHEBI:44423

object_name: benign meningioma


subject: CHEBI:44423

object_name: familial meningioma


subject: CHEBI:44423

object_name: pediatric meningioma


subject: CHEBI:44423

object_name: meningioma


subject: CHEBI:44423

object_name: brain cancer


subject: CHEBI:44423

object_name: brain neoplasm


subject: CHEBI:44423

object_name: cancer


subject: CHEBI:44423

object_name: neoplasm


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: hemophilia A


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: sleep apnea


subject: PUBCHEM.COMPOUND:53477758

object_name: Sleep Apnea, CTCAE


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEBI:48991

object_name: myopia


subject: CHEBI:8884

subject_name: Rocuronium

object_name: respiratory failure


subject: CHEBI:8884

object_name: bronchopulmonary dysplasia


subject: CHEBI:8884

object_name: Respiratory insufficiency


subject: CHEBI:177650

subject_name: Mapracorat

object_name: Surgical procedure finding


subject: CHEBI:177650

object_name: cataract


subject: CHEBI:177650

object_name: Cataract, CTCAE 3.0


subject: CHEBI:177650

object_name: Cataract, CTCAE 5.0


subject: CHEBI:177650

object_name: cataract on exam (physical finding)


subject: CHEBI:177650

object_name: Inflammation


subject: UNII:4B93MGE4AL

subject_name: Futibatinib

object_name: Carcinoma breast stage IV


subject: UNII:4B93MGE4AL

object_name: FGFR2 Gene Amplification


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:45716

subject_name: Vorinostat

object_name: invasive breast carcinoma


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:41774

object_name: malignant neoplasm of breast stage I


subject: CHEBI:41774

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:41774

object_name: Carcinoma breast stage I


subject: CHEBI:41774

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:41774

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:41774

object_name: Breast cancer stage III


subject: CHEBI:41774

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:41774

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C5706368

subject_name: Anti-B7-H3 Antibody-drug Conjugate HS-20093

object_name: pediatric osteosarcoma


subject: UMLS:C5706368

object_name: Osteosarcoma


subject: CHEBI:49140

object_name: Soft tissue rheumatism


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: UMLS:C3713874

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: cancer


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:95165

object_name: adult acute myeloid leukemia


subject: CHEBI:95165

object_name: childhood acute myeloid leukemia


subject: CHEBI:50131

subject_name: Decitabine


subject: UMLS:C5853669

object_name: Persistent corneal epithelial defect


subject: UMLS:C0561938

subject_name: Potassium supplementation (product)

object_name: Blood Pressure Finding


subject: UMLS:C0561938

object_name: Systemic arterial pressure


subject: CHEBI:8988

object_name: Duodenal Cancer


subject: CHEBI:8988

object_name: duodenum cancer


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: UMLS:C5854615

subject_name: PD-L1 Inhibitor INCB099280

object_name: skin squamous cell carcinoma


subject: UMLS:C5854615

object_name: cutaneous squamous cell carcinoma


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:6801

subject_name: Metformin

object_name: malnutrition


subject: UMLS:C1541801

subject_name: TroVax

object_name: clear cell renal carcinoma


subject: UMLS:C5940911


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Unexplained infertility


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:188651

subject_name: Retosiban

object_name: Premature Labor


subject: UMLS:C3254127

subject_name: polyethylene glycol-recombinant human growth hormone

object_name: Short stature of childhood


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0169964

subject_name: somatropin


subject: DRUGBANK:DB16576

subject_name: Cardamom

object_name: Saliva altered


subject: DRUGBANK:DB16576

object_name: Electrolyte imbalance


subject: DRUGBANK:DB16576

object_name: Abnormal blood ion concentration


subject: UMLS:C3887849

subject_name: Cardamom (product)


subject: UMLS:C3887849


subject: UMLS:C3887849


subject: DRUGBANK:DB15615

subject_name: Fennel


subject: DRUGBANK:DB15615


subject: DRUGBANK:DB15615


subject: UMLS:C0032375

subject_name: Oral Poliovirus Vaccine

object_name: Viral gastroenteritis due to Rotavirus


subject: UMLS:C4724802

object_name: ovarian carcinoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Postoperative Complications


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:32150

object_name: calcinosis


subject: CHEBI:132112


subject: CHEBI:9168

subject_name: Sirolimus

object_name: severe combined immunodeficiency


subject: UMLS:C5204514

subject_name: Oral Cancer Vaccine V3-OVA

object_name: ovarian cancer


subject: UMLS:C5204514

object_name: ovarian neoplasm


subject: UMLS:C5204514


subject: CHEBI:17698

subject_name: Chloramphenicol

object_name: analgesia disorder


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: familial lipoprotein lipase deficiency


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: leukemia


subject: UNII:O43472U9X8

object_name: childhood leukemia


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: UMLS:C3641717

subject_name: SUBA-itraconazole

object_name: coccidioidomycosis


subject: UMLS:C3641717

object_name: Primary pulmonary coccidioidomycosis


subject: UMLS:C3641717

object_name: Acute coccidioidomycosis


subject: CHEBI:16236

subject_name: Ethanol

object_name: Complication of hemodialysis


subject: CHEBI:16236


subject: CHEBI:139072

object_name: Depressive Symptoms


subject: CHEBI:8614

subject_name: Psilocybin


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: transitional cell carcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:64019

subject_name: Nebivolol

object_name: Hypertension stage 1


subject: CHEBI:64019

object_name: Hypertension stage 2


subject: CHEBI:87631

subject_name: statin

object_name: type 2 diabetes mellitus


subject: UNII:2834W8D6GK

subject_name: Atabecestat

object_name: Alzheimer disease


subject: UMLS:C5139940


subject: CHEBI:8499

subject_name: Propranolol

object_name: 3-lead electrocardiogram rhythm strip: heart rate


subject: CHEBI:8499

object_name: Amylase, CTCAE


subject: CHEBI:8499

object_name: Memory observations


subject: CHEBI:91512

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: PUBCHEM.COMPOUND:2269

object_name: helminthiasis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: UMLS:C2981856

subject_name: BNC 105P

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5435405

object_name: celiac disease


subject: CHEBI:23359

subject_name: colchicine

object_name: diabetic kidney disease


subject: CHEBI:36796

subject_name: duloxetine

object_name: Fracture of tibial plateau


subject: CHEBI:40799

subject_name: Boldione

object_name: endogenous depression


subject: CHEBI:40799

object_name: major depressive disorder


subject: DRUGBANK:DB19184

object_name: rabies


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: muscular dystrophy


subject: PUBCHEM.COMPOUND:24748496

subject_name: Allisartan isoproxil

object_name: Masked Hypertension


subject: UNII:DI4662MK4N

subject_name: ALLISARTAN ISOPROXIL


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Fetal or neonatal effect of cesarean section


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Non-small cell lung cancer stage III


subject: CHEBI:125427

object_name: EXCESS LMW-DNA


subject: CHEBI:125427

object_name: nephritis


subject: CHEBI:125427

object_name: proteinuria


subject: CHEBI:125427

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:125427

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:125427

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: PUBCHEM.COMPOUND:2269

object_name: Cough


subject: PUBCHEM.COMPOUND:2269

object_name: Cough, CTCAE


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:167473

subject_name: hexopyranose

object_name: congenital disorder of glycosylation


subject: CHEBI:27667

subject_name: b-D-GALACTOSE


subject: CHEBI:28061

subject_name: galactose


subject: CHEBI:12936

subject_name: D-galactose


subject: MESH:C512605

subject_name: Nexrutine

object_name: prostate carcinoma


subject: MESH:C512605

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:56841986

subject_name: Plasmalyte A

object_name: Hyponatremia


subject: PUBCHEM.COMPOUND:56841986

object_name: Hyponatremia, CTCAE


subject: MESH:D000077325

subject_name: Ringer's Lactate


subject: MESH:D000077325


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: kidney neoplasm


subject: UMLS:C1709429


subject: CHEBI:4910

subject_name: Etomidate

object_name: pancreatitis


subject: CHEBI:4910

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:4910

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:4910

object_name: cholangiocarcinoma


subject: CHEBI:4910

object_name: pancreatic neoplasm


subject: CHEBI:4910

object_name: exocrine pancreatic carcinoma


subject: CHEBI:4910

object_name: malignant pancreatic neoplasm


subject: CHEBI:4910

object_name: choledocholithiasis


subject: CHEBI:4910

object_name: Choledocholithiasis


subject: CHEBI:6754

subject_name: Meperidine


subject: CHEBI:6754


subject: CHEBI:6754


subject: CHEBI:6754


subject: CHEBI:6754


subject: CHEBI:6754


subject: CHEBI:6754


subject: CHEBI:6754


subject: CHEBI:6754


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:228488

subject_name: Stiripentol

object_name: Status epilepticus


subject: PUBCHEM.COMPOUND:3664530

subject_name: Cycloastragenol

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:3664530

object_name: Alzheimer disease


subject: UNII:K4YTU42T8G

subject_name: Sebelipase alfa

object_name: Wolman disease


subject: UNII:K4YTU42T8G

object_name: lysosomal acid lipase deficiency


subject: CHEBI:31596

subject_name: Febuxostat

object_name: type 2 diabetes mellitus


subject: CHEBI:31596

object_name: Albuminuria


subject: UMLS:C4318638

subject_name: Quadrivalent Influenza Vaccine

object_name: Pregnant


subject: UMLS:C5553091

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5553091

object_name: clear cell renal carcinoma


subject: UMLS:C5553091

object_name: renal cell adenocarcinoma


subject: UMLS:C5553091

object_name: renal cell carcinoma


subject: UMLS:C5553091

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594355


subject: CHEMBL.COMPOUND:CHEMBL4594355


subject: CHEMBL.COMPOUND:CHEMBL4594355


subject: CHEMBL.COMPOUND:CHEMBL4594355


subject: CHEMBL.COMPOUND:CHEMBL4594355


subject: UMLS:C4724859

subject_name: Geptanolimab


subject: UMLS:C4724859


subject: UMLS:C4724859


subject: UMLS:C4724859


subject: UMLS:C4724859


subject: UMLS:C3896866

subject_name: FGF/FGFR Pathway Inhibitor E7090

object_name: breast neoplasm


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: urothelial carcinoma


subject: CHEBI:85994

object_name: transitional cell carcinoma


subject: UMLS:C0963149

subject_name: Definity

object_name: coronary stenosis


subject: UMLS:C0963149

object_name: carotid stenosis


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:31980


subject: UMLS:C0754326

subject_name: Optison


subject: UMLS:C0754326


subject: CHEBI:125535

subject_name: Esreboxetine

object_name: narcolepsy


subject: CHEBI:125535

object_name: Somnolence


subject: CHEBI:125535

object_name: narcolepsy 1


subject: CHEBI:135342

subject_name: Reboxetine


subject: CHEBI:135342


subject: CHEBI:135342


subject: UMLS:C5239516

subject_name: OrcaGraft

object_name: acute biphenotypic leukemia


subject: UMLS:C5239516

object_name: mixed phenotype acute leukemia


subject: UMLS:C5239516

object_name: acute leukemia of ambiguous lineage


subject: UMLS:C5239516

object_name: acute lymphoblastic leukemia


subject: UMLS:C5239516

object_name: Myelodysplasia


subject: UMLS:C5239516

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5239516

object_name: acute myeloid leukemia


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: esophagitis


subject: UNII:B72HH48FLU

object_name: Esophagitis, CTCAE


subject: GTOPDB:5015

subject_name: leptin

object_name: type 2 diabetes mellitus


subject: GTOPDB:5015

object_name: Insulin resistance


subject: GTOPDB:5015

object_name: partial lipodystrophy


subject: GTOPDB:5015

object_name: congenital generalized lipodystrophy


subject: GTOPDB:5015

object_name: generalized lipodystrophy


subject: CHEBI:81571

subject_name: Leptin


subject: CHEBI:81571


subject: CHEBI:81571


subject: CHEBI:81571


subject: CHEBI:81571


subject: UMLS:C3535635

subject_name: leptin human


subject: UMLS:C3535635


subject: UMLS:C3535635


subject: UMLS:C3535635


subject: UMLS:C3535635


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Gestational diabetes mellitus in pregnancy


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:234112

subject_name: Cenobamate

object_name: epilepsy


subject: CHEBI:234112

object_name: nervous system disorder


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Helicobacter pylori infection


subject: UMLS:C0013227

object_name: Gender


subject: UMLS:C0013227

object_name: sex


subject: UMLS:C0013227

object_name: Sexual intercourse - finding


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UNII:HS813P8QPX

subject_name: bismuth subcitrate


subject: UNII:HS813P8QPX


subject: UNII:HS813P8QPX


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: PUBCHEM.COMPOUND:54675776

subject_name: tetracycline


subject: PUBCHEM.COMPOUND:54675776


subject: PUBCHEM.COMPOUND:54675776


subject: UNII:D07V79Q44T

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UNII:D07V79Q44T

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: CHEBI:15377

subject_name: Water

object_name: brain cancer


subject: CHEBI:15377

object_name: brain neoplasm


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:25187

subject_name: Menthol

object_name: gastric adenoma


subject: CHEBI:25187

object_name: Stomach cancer


subject: CHEBI:25187

object_name: gastric cancer


subject: CHEBI:25187

object_name: COLON NOS POLYPECTOMY TUBULAR ADENOMA


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: Pruritus, CTCAE


subject: UNII:2N4O9L084N

object_name: Pruritus


subject: UNII:2N4O9L084N

object_name: end stage renal failure


subject: UNII:2N4O9L084N

object_name: Chronic uremia


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Muscle Atrophy


subject: CHEBI:50733

object_name: Intensive care unit acquired weakness


subject: CHEBI:50733

object_name: protein-energy malnutrition


subject: CHEBI:50733

object_name: outcomes general quality of life


subject: CHEBI:50733

object_name: Perceived quality of life


subject: CHEBI:50733

object_name: Good quality of life


subject: CHEBI:50733

object_name: metabolic disturbance


subject: CHEBI:50733

object_name: Morphological and Microscopic Findings


subject: MESH:D000077324

subject_name: Crystalloid Solutions

object_name: Sensory Loss


subject: MESH:D000077324

object_name: Disorder of intraocular pressure


subject: MESH:D000077324

object_name: Intraocular Pressure


subject: UMLS:C0056562

subject_name: crystalloid solutions


subject: UMLS:C0056562


subject: UMLS:C0056562


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: UMLS:C1434952

subject_name: Disodium ascorbyl phytostanol phosphates

object_name: Hypercholesterolemia


subject: UMLS:C4305985


subject: CHEBI:135983

subject_name: Teriparatide

object_name: atypical femoral fracture


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:78870

object_name: metabolic syndrome X


subject: CHEBI:78870

object_name: hypertension


subject: CHEBI:78870

object_name: Hypertension, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4297694

subject_name: ANFIBATIDE

object_name: acquired thrombotic thrombocytopenic purpura


subject: UMLS:C3886764

subject_name: Anfibatide


subject: UMLS:C1176021

object_name: von Hippel-Lindau disease


subject: UMLS:C1176021

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C1176021

object_name: clear cell renal carcinoma


subject: UMLS:C1176021

object_name: renal cell adenocarcinoma


subject: UMLS:C1176021

object_name: renal cell carcinoma


subject: UMLS:C1176021

object_name: hemangioblastoma


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: HIV infection


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Nasopharyngeal cancer recurrent


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: Advanced Hepatocellular Carcinoma


subject: UMLS:C1099192

object_name: Inflammation


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE


subject: CHEBI:149509

object_name: hypertrophic cardiomyopathy


subject: CHEBI:149509

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: UMLS:C4085978

subject_name: Anti-pd-1 checkpoint inhibitor pf-06801591

object_name: urothelial carcinoma


subject: UMLS:C4085978

object_name: transitional cell carcinoma


subject: UMLS:C4085978

object_name: malignant soft tissue neoplasm


subject: UMLS:C4085978

object_name: sarcoma


subject: UMLS:C4085978

object_name: melanoma


subject: UMLS:C4085978

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4085978

object_name: non-small cell lung carcinoma


subject: CHEBI:32682

subject_name: L-argininium


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: esophageal squamous cell carcinoma


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Renal Colic, CTCAE


subject: CHEBI:76128

object_name: renal colic


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: CHEBI:6754

subject_name: Meperidine


subject: CHEBI:6754


subject: CHEBI:188197

object_name: Plasma cell myeloma recurrent


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: Achalasia


subject: UNII:6SN82Y9U73

subject_name: FORODESINE HYDROCHLORIDE

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UNII:6SN82Y9U73

object_name: B-cell acute lymphoblastic leukemia


subject: UMLS:C1997549

subject_name: Forodesine hydrochloride


subject: UMLS:C1997549


subject: UMLS:C1175653


subject: UMLS:C1175653


subject: CHEBI:229764

subject_name: Selinexor

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:229764

object_name: chronic myelomonocytic leukemia


subject: CHEBI:8485

subject_name: Proparacaine

object_name: cataract


subject: CHEBI:8485

object_name: Cataract, CTCAE 3.0


subject: CHEBI:8485

object_name: Cataract, CTCAE 5.0


subject: CHEBI:8485

object_name: cataract on exam (physical finding)


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:3368

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:5339

subject_name: Sulfasalazine

object_name: ankylosing spondylitis


subject: UMLS:C1456820

subject_name: Tumor Necrosis Factor-alpha


subject: CHEBI:4875

subject_name: Etanercept

object_name: inclusion body myositis


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: UMLS:C4742301

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C0012802

subject_name: Thiazide Diuretics

object_name: heart failure


subject: UMLS:C0012802

object_name: Heart Failure, CTCAE


subject: CHEBI:291342

subject_name: Desloratadine

object_name: Allergy


subject: CHEBI:291342

object_name: hypersensitivity reaction disease


subject: CHEBI:291342

object_name: Emotional hypersensitivity


subject: UMLS:C3827091

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:231350

subject_name: Pacritinib

object_name: lymphoproliferative syndrome


subject: CHEBI:231350

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:231350

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:231350

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:231350

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:229233

subject_name: Ritlecitinib

object_name: keloid


subject: PUBCHEM.COMPOUND:6536850

object_name: hematologic disorder


subject: PUBCHEM.COMPOUND:6536850


subject: PUBCHEM.COMPOUND:6536850

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:6536850

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PUBCHEM.COMPOUND:6536850

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:6536850

object_name: plasma cell neoplasm


subject: PUBCHEM.COMPOUND:6536850

object_name: plasma cell myeloma


subject: UMLS:C0729218


subject: UMLS:C0729218


subject: UMLS:C0729218


subject: UMLS:C0729218


subject: UMLS:C0729218


subject: UMLS:C0729218


subject: UMLS:C0729218


subject: CHEBI:31547

subject_name: Eplerenone

object_name: essential hypertension


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: ileus


subject: CHEBI:94518

object_name: Ileus, CTCAE


subject: CHEBI:94518

object_name: Tissue Adhesion


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: chronic tic disorder


subject: MESH:C577000

subject_name: hecolin

object_name: viral hepatitis E infection


subject: CHEBI:63629

subject_name: Tizanidine

object_name: Postoperative retention of urine


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Advanced Bile Duct Carcinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:16296

subject_name: D-Tryptophan

object_name: schizophrenia


subject: CHEBI:27897

subject_name: tryptophan


subject: CHEBI:63589

subject_name: Etravirine

object_name: AIDS


subject: CHEBI:31236

object_name: Sequestrum


subject: CHEBI:36796

subject_name: duloxetine


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:6504

object_name: Depressed mood


subject: CHEBI:6504

object_name: Cancer patients and suicide and depression


subject: CHEBI:6504

object_name: Depressed - symptom


subject: CHEBI:6504

object_name: Depression, CTCAE


subject: CHEBI:6504


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:76016

subject_name: Vortioxetine


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Functional abdominal pain


subject: UMLS:C1527137

object_name: Nonulcer dyspepsia


subject: UMLS:C1527137

object_name: irritable bowel syndrome


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEMBL.COMPOUND:CHEMBL2108758

subject_name: PEPPERMINT OIL


subject: CHEMBL.COMPOUND:CHEMBL2108758


subject: UMLS:C5943333

object_name: amaurosis fugax


subject: UMLS:C5943333

object_name: stroke disorder


subject: UMLS:C5943333

object_name: cerebrovascular disorder


subject: UMLS:C5943333

object_name: Stroke (heart beat)


subject: UMLS:C5943333

object_name: Stroke, CTCAE


subject: UMLS:C5943333

object_name: carotid stenosis


subject: UMLS:C5943333

object_name: transient ischemic attack


subject: UMLS:C5943333

object_name: punctate palmoplantar keratoderma type III


subject: UMLS:C5943333

object_name: arteriosclerosis disorder


subject: UMLS:C5943333

object_name: atherosclerosis


subject: UMLS:C3177552

subject_name: Revacept


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C3177552


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: Stomach cancer


subject: UMLS:C1172402

object_name: gastric cancer


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: CHEBI:46058

subject_name: TAXOTERE


subject: CHEBI:46058


subject: CHEBI:85252

subject_name: synaptamide

object_name: infertility


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:3219

subject_name: Bupropion

object_name: Nicotine withdrawal


subject: CHEBI:84500

subject_name: varenicline


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: anus disorder


subject: CHEBI:3160

object_name: anal fissure on exam (physical finding)


subject: CHEBI:3160

object_name: Anal Fissure, CTCAE


subject: CHEBI:3160

object_name: Anal fissure


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Degenerative disorder of cartilage


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:6121

subject_name: Ketamine

object_name: Hypercapnia


subject: CHEBI:90998

subject_name: alvocidib hydrochloride

object_name: Plasma cell myeloma refractory


subject: CHEBI:90998

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:90998

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:90998

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:90998

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:90998

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:90998

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:90998

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:90998

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:90998

object_name: MALT lymphoma


subject: CHEBI:90998

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:90998

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:90998

object_name: splenic marginal zone lymphoma


subject: UMLS:C2709282

subject_name: Alvocidib Hydrochloride


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: UMLS:C2709282


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: keratosis


subject: PUBCHEM.COMPOUND:14907381

object_name: Keratoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:50634

object_name: Hypobaric hypoxia


subject: CHEBI:27690

subject_name: Acetazolamide


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UMLS:C4721879

object_name: lung cancer


subject: UMLS:C4721879

object_name: lung neoplasm


subject: UMLS:C4721879

object_name: lung carcinoma


subject: CHEBI:5613

subject_name: Haloperidol

object_name: Schizophrenia relapse


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:8707

subject_name: Quetiapine


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:82978

subject_name: paliperidone


subject: CHEBI:188072


subject: CHEBI:83804

subject_name: Paliperidone


subject: PUBCHEM.COMPOUND:3916

subject_name: Levopromazine


subject: CHEBI:6838

subject_name: levomepromazine


subject: CHEBI:8028

subject_name: Perphenazine


subject: CHEBI:47426

subject_name: Furosemide

object_name: keloid


subject: CHEBI:47426

object_name: Cicatrix, Hypertrophic


subject: CHEBI:29013

subject_name: Fusidic acid


subject: CHEBI:29013


subject: UMLS:C2352429

subject_name: imvamune

object_name: basal cell carcinoma


subject: UMLS:C2352429

object_name: skin basal cell carcinoma


subject: UMLS:C2352429

object_name: squamous cell carcinoma


subject: UMLS:C2352429

object_name: skin carcinoma


subject: CHEBI:16919

subject_name: Creatine

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEBI:8499

subject_name: Propranolol

object_name: undifferentiated pleomorphic sarcoma


subject: CHEBI:8499

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: CHEBI:8499

object_name: pediatric angiosarcoma


subject: CHEBI:8499

object_name: angiosarcoma


subject: CHEBI:8499

object_name: Adult Angiosarcoma


subject: UNII:IZT740JY57

object_name: cancer


subject: UNII:IZT740JY57

object_name: neoplasm


subject: UNII:IZT740JY57


subject: UMLS:C3501154


subject: UMLS:C3501154


subject: UMLS:C3501154


subject: UMLS:C0972569

subject_name: Electrophoresis Gel

object_name: cardiovascular disorder


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: PUBCHEM.COMPOUND:71080313

subject_name: Volasertib

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:71080313

object_name: childhood acute myeloid leukemia


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: Insulin Sensitivity


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:YW45RY9QD4

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C0284216


subject: CHEBI:42797

subject_name: Gabapentin

object_name: knee pain chronic


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: glucose metabolism disease


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: atrophic vulva


subject: PUBCHEM.COMPOUND:134506

object_name: Genitourinary syndrome of menopause


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:85252


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: GTOPDB:12347

subject_name: penpulimab

object_name: adult lymphoma


subject: GTOPDB:12347

object_name: lymphoma


subject: GTOPDB:12347

object_name: pediatric lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: head and neck squamous cell carcinoma


subject: CHEBI:39867

subject_name: Valproic acid


subject: UMLS:C5239410

subject_name: CBD Oil

object_name: Chronic inflammation


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class

object_name: tuberculosis


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Drug Interactions


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Post-kala-azar dermal leishmaniasis


subject: UMLS:C0042210

object_name: leishmaniasis


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IIIC Ovarian Cancer


subject: UNII:M89N0Q7EQR

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:M89N0Q7EQR

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Ovarian cancer stage IV


subject: UNII:M89N0Q7EQR

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:M89N0Q7EQR

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: ovarian clear cell cancer


subject: UNII:M89N0Q7EQR

object_name: ovarian serous adenocarcinoma


subject: UNII:M89N0Q7EQR

object_name: malignant ovarian serous tumor


subject: PR:000001379

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8